Cancer News and Research

RSS
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.
Researchers identify gene variant associated with childhood asthma

Researchers identify gene variant associated with childhood asthma

Absence of TRIM37 protein boosts genetic instability in patients with Mulibrey syndrome

Absence of TRIM37 protein boosts genetic instability in patients with Mulibrey syndrome

Scientists map previously unknown metabolic pathways to produce memory T cell

Scientists map previously unknown metabolic pathways to produce memory T cell

Researchers sequence 64 human genomes at high resolution

Researchers sequence 64 human genomes at high resolution

Molecular mapping of proteins shows promise for treating cancer

Molecular mapping of proteins shows promise for treating cancer

Study reveals new functions of ENDOU enzymes

Study reveals new functions of ENDOU enzymes

Setting new standards for the exchange of human omics data

Setting new standards for the exchange of human omics data

Machine learning algorithm helps differentiate benign and premalignant colorectal polyps

Machine learning algorithm helps differentiate benign and premalignant colorectal polyps

New gene-editing technique allows for pre-programming of sequential edits

New gene-editing technique allows for pre-programming of sequential edits

Human monoclonal antibodies can act as biological substitute for chemical antibiotics

Human monoclonal antibodies can act as biological substitute for chemical antibiotics

New technology identifies useful genetic designs more efficiently

New technology identifies useful genetic designs more efficiently

Epigenetic therapy can boost the ability of immune killer T-cells to destroy cancer cells

Epigenetic therapy can boost the ability of immune killer T-cells to destroy cancer cells

Longevity gene contributes to brain health during aging

Longevity gene contributes to brain health during aging

A functional test to measure the effect of inherited gene variants in breast and ovarian cancer

A functional test to measure the effect of inherited gene variants in breast and ovarian cancer

New research on mitochondrial function can play significant part in serious disease

New research on mitochondrial function can play significant part in serious disease

Electron cryo-microscopy sheds light on how bioenergy makers are made in our body

Electron cryo-microscopy sheds light on how bioenergy makers are made in our body

New tool helps decode the language used by cells

New tool helps decode the language used by cells

Study reveals novel antibody binding implicated in liver and breast cancer

Study reveals novel antibody binding implicated in liver and breast cancer

New hydrogel shrinks tumors in melanoma mice model

New hydrogel shrinks tumors in melanoma mice model

Study identifies how CTLA-4 blockade can disable suppressive immune cells to aid tumor destruction

Study identifies how CTLA-4 blockade can disable suppressive immune cells to aid tumor destruction

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.